Logo

Merck and GSK Announce Global Alliance to Jointly Develop and ...

DARMSTADT, Germany, Feb. 5, 2019 /PRNewswire-AsiaNet/ -- Not intended for US, Canada or UK-based media- Eight high priority immuno-oncology clinical development studies ongoing or expected to commence in 2019, including studies in non-small cell lung and biliary tract cancers - Merck w...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Asian Spectator by NewsServices.com - office@NewsServices.com - 1300 660 660